80 FR 24932 - Request for the Technical Review of 19 Draft Skin Notation Assignments and Skin Notation Profiles
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 80, Issue 84 (May 1, 2015)
Centers for Disease Control and Prevention
Federal Register Volume 80, Issue 84 (May 1, 2015)
| Page Range | 24932-24934 | |
| FR Document | 2015-10289 |
[Federal Register Volume 80, Number 84 (Friday, May 1, 2015)] [Notices] [Pages 24932-24934] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-10289] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket Number CDC-2015-0021, NIOSH 153-C] Request for the Technical Review of 19 Draft Skin Notation Assignments and Skin Notation Profiles AGENCY: National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Request for information and comment. ----------------------------------------------------------------------- SUMMARY: The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) is conducting a public review of the draft skin notations and supporting technical documents entitled, Skin Notations Profiles, for 19 chemicals. NIOSH is requesting technical reviews of the draft Skin Notation Profiles. DATES: Electronic or written comments must be received by June 30, 2015. ADDRESSES: You may submit comments, identified by CDC-2015-0021 and docket number NIOSH 153-C, by any of the following methods:Federal eRulemaking Portal: www.regulations.gov. Follow the instructions for submitting comments. Mail: National Institute for Occupational Safety and Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C-34, Cincinnati, Ohio 45226-1998. Instructions: All information received in response to this notice must include the agency name and docket number [CDC-2015-0021; NIOSH 153-C]. All relevant comments received will be posted without change to www.regulations.gov, including any personal information provided. All electronic comments should be formatted as Microsoft Word. For access to the docket to read background documents or comments received, go to www.regulations.gov. All information received in response to this notice will also be available for public examination and copying at the NIOSH Docket Office, 1150 Tusculum Avenue, Room 155, Cincinnati, OH 45226-1998. FOR FURTHER INFORMATION CONTACT: Naomi Hudson, NIOSH Robert A. Taft Laboratories, MS-C32, 1190 Tusculum Ave., Cincinnati, OH 45226. (513)533-8388 (not a toll free number). SUPPLEMENTARY INFORMATION: This review follows the publication of 22 Skin Notation Profiles, Docket Number NIOSH 153-A http://www.cdc.gov/niosh/docket/archive/docket153A.html and the external review of an additional 25 Skin Notation Profiles, Docket Number NIOSH 153-B http://www.cdc.gov/niosh/docket/archive/docket153B.html. To facilitate the review of these documents, NIOSH requests that the following questions be taken into consideration for each Skin Notation Profile: 1. Does this document clearly outline the systemic health hazards associated with exposures of the skin to the chemical? If not, what specific information is missing from the document? 2. If the SYS or SYS (FATAL) notations are assigned, are the rationale and logic behind the assignment clear? If not assigned, is the logic clear why it was not (e.g., insufficient data, no identified health hazard)? 3. Does this document clearly outline the direct (localized) health hazards [[Page 24933]] associated with exposures of the skin to the chemical? If not, what specific information is missing from the document? 4. If the DIR, DIR (IRR), or DIR (COR) notations are assigned, are the rationale and logic behind the assignment clear? If not assigned, is the logic clear why it was not (e.g., insufficient data, no identified health hazard)? 5. Does this document clearly outline the immune-mediated responses (allergic response) health hazards associated with exposures of the skin to the chemical? If not, what specific information is missing from the document? 6. If the SEN notation is assigned, are the rationale and logic behind the assignment clear? If not assigned, is the logic clear why it was not (e.g., insufficient data, no identified health hazard)? 7. If the ID (SK) or SK were assigned, are the rationale and logic outlined within the document? 8. Are the conclusions supported by the data? 9. Are the tables clear and appropriate? 10. Is the document organized appropriately? If not, what improvements are needed? 11. Are you aware of any scientific data reported in governmental publications, databases, peer-reviewed journals, or other sources that should be included within this document? In 2009, NIOSH published Current Intelligence Bulletin (CIB) 61--A Strategy for assigning New NIOSH Skin Notations [NIOSH 2009-147; http://www.cdc.gov/niosh/docs/2009-147/pdfs/2009-147.pdf]. The CIB presents a strategic framework that is a form of hazard identification that has been designed to do the following: 1. Ensure that the assigned skin notations reflect the contemporary state of scientific knowledge 2. Provide transparency behind the assignment process 3. Communicate the hazards of chemical exposures of the skin 4. Meet the needs of health professionals, employers, and other interested parties in protecting workers from chemical contact with the skin. This strategy involves the assignment of multiple skin notations for distinguishing systemic (SYS), direct (DIR), and sensitizing (SEN) effects caused by exposure of skin (SK) to chemicals. Chemicals that are highly or extremely toxic and may be potentially lethal or life- threatening following exposures of the skin are designated with the systemic subnotation (FATAL). Potential irritants and corrosive chemicals are indicated by the direct effects subnotations (IRR) and (COR), respectively. Thus with the new strategy, chemicals labeled as SK: SYS are recognized to contribute to systemic toxicity through dermal absorption. Chemicals assigned the notation SK: SYS (FATAL) have been identified as highly or extremely toxic and have the potential to be lethal or life-threatening following acute contact with the skin. Substances identified to cause direct effects (i.e., damage or destruction) to the skin limited to or near the point of contact are labeled SK: DIR, and those resulting in skin irritation and corrosion at the point of contact are labeled as SK: DIR (IRR) and SK: DIR (COR), respectively. The SK: SEN notation is used for substances identified as causing or contributing to allergic contact dermatitis (ACD) or other immune-mediated responses, such as airway hyper reactivity (asthma). Candidate chemicals may be assigned more than one skin notation when they are identified to cause multiple effects resulting from skin exposure. For example, if a chemical is identified as corrosive and also contributes to systemic toxicity, it will be labeled as SK: SYS- DIR (COR). When scientific data for a chemical indicate that skin exposure does not produce systemic, direct, or sensitizing effects, the compound will be assigned the notation (SK). The ID(SK) notation is assigned to indicate that insufficient data on the health hazards associated with skin exposure to a substance exist at the time of the review to determine whether the chemical has the potential to act as a systemic, direct, or sensitizing agent. The ND notation indicates that a chemical has not been evaluated by the strategy outlined in this CIB and that the health hazards associated with skin exposure are unknown. Historically, skin notations have been published in the NIOSH Pocket Guide to Chemical Hazards [NIOSH 2005-149, http://www.cdc.gov/niosh/npg/]. This practice will continue with the NIOSH skin notation assignments for each evaluated chemical being integrated as they become available. A support document called a Skin Notation Profile has been developed for each evaluated chemical. NIOSH submitted the first group of Skin Notation Profiles for external review in 2010 [75 FR 22148] and published the finalized reports in 2011 [http://www.cdc.gov/niosh/topics/skin/skin-notation_profiles.html]. The Skin Notation Profile for a chemical is intended to provide information supplemental to the skin notation, including a summary of all relevant data used to aid in determining the hazards associated with skin exposures. NIOSH seeks comments on the draft skin notation assignments and Skin Notation Profiles for 19 chemicals. The draft Skin Notation Profiles were developed to provide the scientific rationale behind the hazard-specific skin notation (SK) assignments for the following chemicals: ------------------------------------------------------------------------ Substance(s) ------------------------------------------------------------------------ Trichloroethylene.................... (CAS #79-01-06) Acrylic acid......................... (CAS #79-10-7) Tetraethyl lead...................... (CAS #78-00-2) Tetramethyl lead..................... (CAS #75-74-1) 2-Hydropropyl acrylate............... (CAS #999-61-1) Dimethyl sulfate..................... (CAS #77-78-1) Arsenic.............................. (CAS #7440-38-2) Pentachlorophenol.................... (CAS #87-86-5) Dichlorvos........................... (CAS #62-73-7) Heptachlor........................... (CAS #76-44-8) Disulfoton........................... (CAS #298-04-4) Atrazine............................. (CAS #1912-24-9) Morpholine........................... (CAS #110-91-8) EPN.................................. (CAS #2104-64-5) Sodium fluoroacetate................. (CAS #62-74-8) Chlorinated camphene................. (CAS #8001-35-2) Dioxathion........................... (CAS#78-34-2) Catechol............................. (CAS #120-80-9) [[Page 24934]] 1-Bromopropane....................... (CAS #106-94-5) ------------------------------------------------------------------------ Each Skin Notation Profile provides a detailed summary of the health hazards of skin contact and rationale for the proposed SK assignment with the chemical(s) of interest. Dated: April 22, 2015. John Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. [FR Doc. 2015-10289 Filed 4-30-15; 8:45 am] BILLING CODE 4163-19-P
![24932 Federal Register / Vol. 80, No. 84 / Friday, May 1, 2015 / Notices
state, tribal, local, or territorial health the public health workforce, where administration (i.e., 1 year, or 3 years
agencies, or non-governmental alumni are employed, what topical and post-PHAP graduation). The language,
organizations), focusing on public functional public health areas alumni however, will be updated for each
health or health/healthcare. support (e.g., chronic disease, infectious assessment administration to reflect the
When PHAP originated in 2007, the disease, assessment, communications, appropriate time period. It is estimated
program focused on increasing etc.), to what extent alumni support the that there will be no more than 480
recruitment and enrollment; to date, capabilities of public health agencies at respondents (160 respondents annually)
there has been limited systematic the federal, state, territorial, local, tribal, over the course of the three year
assessment of the program. As a result, and non-governmental organizational approval period. Assessments will be
one current program priority is focused levels, and to what extent PHAP has
administered electronically; each
on documenting program outcomes to influenced alumni career paths (if at
inform refinements to program alumnus will receive an embedded link
all). Information will be used to answer
processes and activities, demonstrate key program assessment questions, in an email invitation that is unique to
program impact, and inform decision specifically: ‘‘Is PHAP a quality that alumnus; each alumnus will only
making about future program direction. program?’’, ‘‘Is PHAP an effective have access to his/her link to the
The purpose of this information program?’’, and ‘‘What is the impact of assessment Web site. The total
collection request (ICR) is to gain PHAP?’’ estimated burden is 8 minutes per
approval to follow alumni career CDC will administer the PHAP respondent per assessment. The total
progression following participation in Alumni Assessment at two different annualized estimated burden is 21
PHAP. The ICR will enable the program time points (1 year post-graduation, and hours.
to demonstrate evidence of program 3 years post-graduation) to PHAP There are no costs to respondents
outcomes, specifically to document how alumni. Assessment questions will except their time.
many alumni are retained as members of remain consistent at each
ESTIMATED ANNUALIZED BURDEN HOURS
Average
Number of
Number of burden per
Type of respondent Form name responses per
respondents response
respondent (in hours)
PHAP Alumni .................................................. PHAP Alumni Assessment ............................. 160 1 8/60
Leroy A. Richardson, skin notations and supporting technical Office, 1150 Tusculum Avenue, Room
Chief, Information Collection Review Office, documents entitled, Skin Notations 155, Cincinnati, OH 45226–1998.
Office of Scientific Integrity, Office of the Profiles, for 19 chemicals. NIOSH is FOR FURTHER INFORMATION CONTACT:
Associate Director for Science, Office of the requesting technical reviews of the draft Naomi Hudson, NIOSH Robert A. Taft
Director, Centers for Disease Control and Skin Notation Profiles.
Prevention.
Laboratories, MS–C32, 1190 Tusculum
DATES:Electronic or written comments Ave., Cincinnati, OH 45226. (513)533–
[FR Doc. 2015–10183 Filed 4–30–15; 8:45 am]
must be received by June 30, 2015. 8388 (not a toll free number).
BILLING CODE 4163–18–P
SUPPLEMENTARY INFORMATION: This
ADDRESSES: You may submit comments,
identified by CDC–2015–0021 and review follows the publication of 22
DEPARTMENT OF HEALTH AND docket number NIOSH 153–C, by any of Skin Notation Profiles, Docket Number
HUMAN SERVICES the following methods: NIOSH 153–A http://www.cdc.gov/
niosh/docket/archive/docket153A.html
• Federal eRulemaking Portal: and the external review of an additional
Centers for Disease Control and
www.regulations.gov. Follow the 25 Skin Notation Profiles, Docket
Prevention
instructions for submitting comments. Number NIOSH 153–B http://
[Docket Number CDC–2015–0021, NIOSH • Mail: National Institute for www.cdc.gov/niosh/docket/archive/
153–C] Occupational Safety and Health, NIOSH docket153B.html. To facilitate the
Docket Office, 1090 Tusculum Avenue, review of these documents, NIOSH
Request for the Technical Review of 19 MS C–34, Cincinnati, Ohio 45226–1998.
Draft Skin Notation Assignments and requests that the following questions be
Instructions: All information received taken into consideration for each Skin
Skin Notation Profiles
in response to this notice must include Notation Profile:
AGENCY: National Institute for the agency name and docket number 1. Does this document clearly outline
Occupational Safety and Health [CDC–2015–0021; NIOSH 153–C]. All the systemic health hazards associated
(NIOSH) of the Centers for Disease relevant comments received will be with exposures of the skin to the
Control and Prevention (CDC), posted without change to chemical? If not, what specific
Department of Health and Human www.regulations.gov, including any information is missing from the
Services (HHS). personal information provided. All document?
mstockstill on DSK4VPTVN1PROD with NOTICES
ACTION: Request for information and electronic comments should be 2. If the SYS or SYS (FATAL)
comment. formatted as Microsoft Word. For access notations are assigned, are the rationale
to the docket to read background and logic behind the assignment clear?
SUMMARY: The National Institute for documents or comments received, go to If not assigned, is the logic clear why it
Occupational Safety and Health www.regulations.gov. All information was not (e.g., insufficient data, no
(NIOSH) of the Centers for Disease received in response to this notice will identified health hazard)?
Control and Prevention (CDC) is also be available for public examination 3. Does this document clearly outline
conducting a public review of the draft and copying at the NIOSH Docket the direct (localized) health hazards
VerDate Sep<11>2014 18:14 Apr 30, 2015 Jkt 235001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\01MYN1.SGM 01MYN1](https://thefederalregister.org/doc/80_FR_25016/page/1.svg)
![Federal Register / Vol. 80, No. 84 / Friday, May 1, 2015 / Notices 24933
associated with exposures of the skin to 2. Provide transparency behind the systemic toxicity, it will be labeled as
the chemical? If not, what specific assignment process SK: SYS–DIR (COR). When scientific
information is missing from the 3. Communicate the hazards of data for a chemical indicate that skin
document? chemical exposures of the skin exposure does not produce systemic,
4. If the DIR, DIR (IRR), or DIR (COR) 4. Meet the needs of health direct, or sensitizing effects, the
notations are assigned, are the rationale professionals, employers, and other compound will be assigned the notation
and logic behind the assignment clear? interested parties in protecting workers (SK). The ID(SK) notation is assigned to
If not assigned, is the logic clear why it from chemical contact with the skin. indicate that insufficient data on the
was not (e.g., insufficient data, no This strategy involves the assignment health hazards associated with skin
identified health hazard)? of multiple skin notations for exposure to a substance exist at the time
5. Does this document clearly outline distinguishing systemic (SYS), direct of the review to determine whether the
the immune-mediated responses (DIR), and sensitizing (SEN) effects chemical has the potential to act as a
(allergic response) health hazards caused by exposure of skin (SK) to systemic, direct, or sensitizing agent.
associated with exposures of the skin to chemicals. Chemicals that are highly or The ND notation indicates that a
the chemical? If not, what specific extremely toxic and may be potentially chemical has not been evaluated by the
information is missing from the lethal or life-threatening following strategy outlined in this CIB and that the
document? exposures of the skin are designated health hazards associated with skin
6. If the SEN notation is assigned, are with the systemic subnotation (FATAL).
the rationale and logic behind the exposure are unknown.
Potential irritants and corrosive
assignment clear? If not assigned, is the Historically, skin notations have been
chemicals are indicated by the direct
logic clear why it was not (e.g., published in the NIOSH Pocket Guide to
effects subnotations (IRR) and (COR),
insufficient data, no identified health Chemical Hazards [NIOSH 2005–149,
respectively. Thus with the new
hazard)? http://www.cdc.gov/niosh/npg/]. This
strategy, chemicals labeled as SK: SYS
7. If the ID (SK) or SK were assigned, practice will continue with the NIOSH
are recognized to contribute to systemic
are the rationale and logic outlined skin notation assignments for each
toxicity through dermal absorption.
within the document? evaluated chemical being integrated as
8. Are the conclusions supported by Chemicals assigned the notation SK:
SYS (FATAL) have been identified as they become available. A support
the data? document called a Skin Notation Profile
9. Are the tables clear and highly or extremely toxic and have the
potential to be lethal or life-threatening has been developed for each evaluated
appropriate? chemical. NIOSH submitted the first
10. Is the document organized following acute contact with the skin.
Substances identified to cause direct group of Skin Notation Profiles for
appropriately? If not, what external review in 2010 [75 FR 22148]
improvements are needed? effects (i.e., damage or destruction) to
the skin limited to or near the point of and published the finalized reports in
11. Are you aware of any scientific
contact are labeled SK: DIR, and those 2011 [http://www.cdc.gov/niosh/topics/
data reported in governmental
resulting in skin irritation and corrosion skin/skin-notation_profiles.html]. The
publications, databases, peer-reviewed
at the point of contact are labeled as SK: Skin Notation Profile for a chemical is
journals, or other sources that should be
DIR (IRR) and SK: DIR (COR), intended to provide information
included within this document?
In 2009, NIOSH published Current respectively. The SK: SEN notation is supplemental to the skin notation,
Intelligence Bulletin (CIB) 61—A used for substances identified as including a summary of all relevant data
Strategy for assigning New NIOSH Skin causing or contributing to allergic used to aid in determining the hazards
Notations [NIOSH 2009–147; http:// contact dermatitis (ACD) or other associated with skin exposures.
www.cdc.gov/niosh/docs/2009-147/ immune-mediated responses, such as NIOSH seeks comments on the draft
pdfs/2009-147.pdf]. The CIB presents a airway hyper reactivity (asthma). skin notation assignments and Skin
strategic framework that is a form of Candidate chemicals may be assigned Notation Profiles for 19 chemicals. The
hazard identification that has been more than one skin notation when they draft Skin Notation Profiles were
designed to do the following: are identified to cause multiple effects developed to provide the scientific
1. Ensure that the assigned skin resulting from skin exposure. For rationale behind the hazard-specific
notations reflect the contemporary state example, if a chemical is identified as skin notation (SK) assignments for the
of scientific knowledge corrosive and also contributes to following chemicals:
Substance(s)
Trichloroethylene ......................................................................................................................................................................... (CAS #79–01–06)
Acrylic acid .................................................................................................................................................................................. (CAS #79–10–7)
Tetraethyl lead ............................................................................................................................................................................. (CAS #78–00–2)
Tetramethyl lead .......................................................................................................................................................................... (CAS #75–74–1)
2-Hydropropyl acrylate ................................................................................................................................................................ (CAS #999–61–1)
Dimethyl sulfate ........................................................................................................................................................................... (CAS #77–78–1)
Arsenic ......................................................................................................................................................................................... (CAS #7440–38–2)
Pentachlorophenol ....................................................................................................................................................................... (CAS #87–86–5)
Dichlorvos .................................................................................................................................................................................... (CAS #62–73–7)
Heptachlor ................................................................................................................................................................................... (CAS #76–44–8)
mstockstill on DSK4VPTVN1PROD with NOTICES
Disulfoton ..................................................................................................................................................................................... (CAS #298–04–4)
Atrazine ....................................................................................................................................................................................... (CAS #1912–24–9)
Morpholine ................................................................................................................................................................................... (CAS #110–91–8)
EPN ............................................................................................................................................................................................. (CAS #2104–64–5)
Sodium fluoroacetate .................................................................................................................................................................. (CAS #62–74–8)
Chlorinated camphene ................................................................................................................................................................ (CAS #8001–35–2)
Dioxathion .................................................................................................................................................................................... (CAS#78–34–2)
Catechol ...................................................................................................................................................................................... (CAS #120–80–9)
VerDate Sep<11>2014 18:14 Apr 30, 2015 Jkt 235001 PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 E:\FR\FM\01MYN1.SGM 01MYN1](https://thefederalregister.org/doc/80_FR_25016/page/2.svg)
![24934 Federal Register / Vol. 80, No. 84 / Friday, May 1, 2015 / Notices
Substance(s)
1-Bromopropane .......................................................................................................................................................................... (CAS #106–94–5)
Each Skin Notation Profile provides a OMB control number. To be assured information they conduct or sponsor.
detailed summary of the health hazards consideration, comments and The term ‘‘collection of information’’ is
of skin contact and rationale for the recommendations must be submitted in defined in 44 U.S.C. 3502(3) and 5 CFR
proposed SK assignment with the any one of the following ways: 1320.3(c) and includes agency requests
chemical(s) of interest. 1. Electronically. You may send your or requirements that members of the
Dated: April 22, 2015. comments electronically to http:// public submit reports, keep records, or
John Howard,
www.regulations.gov. Follow the provide information to a third party.
instructions for ‘‘Comment or Section 3506(c)(2)(A) of the PRA
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
Submission’’ or ‘‘More Search Options’’ requires federal agencies to publish a
and Prevention. to find the information collection 60-day notice in the Federal Register
[FR Doc. 2015–10289 Filed 4–30–15; 8:45 am]
document(s) that are accepting concerning each proposed collection of
comments. information, including each proposed
BILLING CODE 4163–19–P
2. By regular mail. You may mail extension or reinstatement of an existing
written comments to the following collection of information, before
DEPARTMENT OF HEALTH AND address: CMS, Office of Strategic submitting the collection to OMB for
HUMAN SERVICES Operations and Regulatory Affairs, approval. To comply with this
Division of Regulations Development, requirement, CMS is publishing this
Centers for Medicare & Medicaid Attention: Document Identifier/OMB notice.
Services Control Number llll, Room C4–26–
05, 7500 Security Boulevard, Baltimore, Information Collection
[Document Identifiers: CMS–10261, CMS– Maryland 21244–1850. 1. Type of Information Collection
10185 and CMS–2540–10]
To obtain copies of a supporting Request: Revision of a currently
Agency Information Collection statement and any related forms for the approved collection; Title of
Activities: Proposed Collection; proposed collection(s) summarized in Information Collection: Part C Medicare
Comment Request this notice, you may make your request Advantage Reporting Requirements and
using one of following: Supporting Regulations; Use: There are
AGENCY: Centers for Medicare & 1. Access CMS’ Web site address at a number of information users of Part C
Medicaid Services. http://www.cms.hhs.gov/ reporting data, including our central
ACTION: Notice. PaperworkReductionActof1995. and regional office staff that use this
2. Email your request, including your information to monitor health plans and
SUMMARY: The Centers for Medicare & address, phone number, OMB number, to hold them accountable for their
Medicaid Services (CMS) is announcing and CMS document identifier, to performance, researchers, and other
an opportunity for the public to Paperwork@cms.hhs.gov. government agencies such as the
comment on CMS’ intention to collect 3. Call the Reports Clearance Office at Government Accounting Office. Health
information from the public. Under the (410) 786–1326. plans can use this information to
Paperwork Reduction Act of 1995 (the measure and benchmark their
FOR FURTHER INFORMATION CONTACT:
PRA), federal agencies are required to performance. Form Number: CMS–
Reports Clearance Office at (410) 786–
publish notice in the Federal Register 10261 (OMB Control Number 0938–
1326.
concerning each proposed collection of 1054); Frequency: Yearly and semi-
information (including each proposed SUPPLEMENTARY INFORMATION:
annually; Affected Public: Private sector
extension or reinstatement of an existing Contents (business or other for-profits); Number
collection of information) and to allow of Respondents: 561; Total Annual
60 days for public comment on the This notice sets out a summary of the
use and burden associated with the Responses: 3,508; Total Annual Hours:
proposed action. Interested persons are 201,503. (For policy questions regarding
invited to send comments regarding our following information collections. More
detailed information can be found in this collection contact Terry Lied at
burden estimates or any other aspect of 410–786–8973).
this collection of information, including each collection’s supporting statement
and associated materials (see 2. Type of Information Collection
any of the following subjects: (1) The Request: Revision of a currently
necessity and utility of the proposed ADDRESSES).
approved collection; Title of
information collection for the proper CMS–10261 Part C Medicare Information Collection: Medicare Part D
performance of the agency’s functions; Advantage Reporting Requirements and Reporting Requirements and Supporting
(2) the accuracy of the estimated Supporting Regulations Regulations; Use: To ensure quality
burden; (3) ways to enhance the quality, provision of the Medicare Prescription
utility, and clarity of the information to CMS–10185 Medicare Part D
Reporting Requirements and Drug Benefit to beneficiaries, the
be collected; and (4) the use of collected information will serve as an
automated collection techniques or Supporting Regulations
mstockstill on DSK4VPTVN1PROD with NOTICES
integral resource for oversight,
other forms of information technology to CMS–2540 Skilled Nursing Facility monitoring, compliance, and auditing
minimize the information collection and Skilled Nursing Facility Health activities. Sponsors should retain
burden. Care Complex Cost Report Form documentation and data records related
DATES: Comments must be received by Under the PRA (44 U.S.C. 3501– to their data submissions. Data will be
June 30, 2015: 3520), federal agencies must obtain validated, analyzed, and utilized for
ADDRESSES: When commenting, please approval from the Office of Management trend reporting. For CY 2016 reporting,
reference the document identifier or and Budget (OMB) for each collection of the following sections will be reported
VerDate Sep<11>2014 18:14 Apr 30, 2015 Jkt 235001 PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 E:\FR\FM\01MYN1.SGM 01MYN1](https://thefederalregister.org/doc/80_FR_25016/page/3.svg)
Document Created: 2018-02-21 10:20:49
Document Modified: 2018-02-21 10:20:49
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Request for information and comment. | |
| Dates | Electronic or written comments must be received by June 30, 2015. | |
| Contact | Naomi Hudson, NIOSH Robert A. Taft Laboratories, MS-C32, 1190 Tusculum Ave., Cincinnati, OH 45226. (513)533-8388 (not a toll free number). | |
| FR Citation | 80 FR 24932 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR